LONDON (Dispatches) - Pfizer and Moderna, the manufacturers of two of the most effective COVID-19 vaccines, have raised the prices of their jabs in their latest European Union (EU) supply contracts, according to a report in the Financial Times newspaper (FT).
The new price for the Pfizer shot was 19.50 euros ($23.15) compared with 15.50 euros ($18.39) previously, the media outlet said, citing portions of the contracts it had seen.
The price of a dose of the Moderna vaccine was set at $25.50, according to the contracts, compared with $22.60 in the first procurement deal, although lower than the previously agreed $28.50 because the order was larger, the FT said, citing one official close to the matter.
EU countries are keen to stamp out the spread of the Delta variant and the EU and countries beyond are mulling the possibility of administering a booster jab to improve efficacy.
Pfizer declined to comment on the contract with the European Commission (EC), citing confidentiality. “Beyond the redacted contract(s) published by the EC, the content remains confidential and so we won’t be commenting,” the company said.